Metabolomics: From liver chiromancy to personalized precision medicine in advanced chronic liver disease

doi:10.4254/wjh.v10.i3.371

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6450)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

432

WORD

292

HTML

3138

Figures (1-1)

170

Tables (1-1)

194

Sum=4226

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

959

Download

1265

Sum=2224

Mar 27, 2018 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Mar 27, 2018; 10(3): 371-378
Published online Mar 27, 2018. doi: 10.4254/wjh.v10.i3.371

Table 1 Principal metabolic changes in advanced liver diseases

Condition	Lipids	Bile acids	Carbo-hydrates	Energy and oxidative stress	Proteins and Aminoacids
ACLD	↓ HDL cholesterol		↑ Glucose	↓ OH-butyrate	↑ Phe
	↓ Choline		↑ Glycerol	↓ Aceto-acetate	↓ Gli, Ala
	↓ Phosphatidylcholine			↑ Lactate	↓ Branched AA
	↓ Lipid moieties			↑ Pyruvate	↑ Leu, Iso-Leu, Val, Glu
				↑ Citrate	↑ Methionine
ACLF	↓ HDL cholesterol			↑ Lactate	↑ Aromatic AA
ACLF	↓ HDL cholesterol			↑ Pyruvate	↑ Aromatic AA
ALD	↓ Lyso-phosphatidilcholine	↑ Sulphated bile acids	↑ Fumarate, succinate,	↑ Indole 3-acetic acid (u)	↓ Val, Iso-Leu
	↑ Eico/doco -sapentaenoate		malate, citrate	↑ Betaine
	↑ Tetra/hexa/octa -decanedioate		↑ Xylonate	↑ Citruline
HCC	↓ Lysophosphatidilcholine	↓ (Lito)cholic, (cheno)deoxy-cholic acids	↑ Glucose, glycerol	↓ OH-butyrate	↓ BCAAs: Leu, Iso-Leu and Val
	↑ Oleamide	↓ (Lito)cholic, (cheno)deoxy-cholic acids		↓ Xantine	↓ BCAAs: Leu, Iso-Leu and Val
	↑ Stearoyl-coa desaturase	↓ GCA, GDCA, GCDCA, TCA, TCDCA		↑ Canavanino succinate	↑ AAAs: Phe, Trp, Tyr, His
	↓ 3-Hydroxybutyrate	↓ GCA, GDCA, GCDCA, TCA, TCDCA		↑ Canavanino succinate	↑ AAAs: Phe, Trp, Tyr, His
	↓ Choline				↑ Methionine, hydroxy-methyldeoxyuridine, dimethyl-guanosine, uric acid
	↓ Choline				↑ Methylhistidine

ACLF: Acute on chronic liver failure; ACLD: Advanced chronic liver disease; ALD: Alcoholic liver disease; HCC: Hepatocellular carcinoma; AA: Aminoacids; AAA: Aromatic AA; BCAA: Branched chain AA; Ala: Alanine; Arg: Arginine; Gli: Glicine; Glu: Glutamate; His: Histidine; Phe: Phenylalanine; Leu: Leucine; Val: Valine; Trp: Triptofan; Tyr: Tyrosine; CA: Cholic acid; GCA: Glyco CA; GDCA: Glycodeoxy CA; GCDCA: Glycochenodeoxy CA; TCA: Tauro CA; TCDA: Tauro cheno deoxi CA; u: Urinary.

Citation: Procopet B, Fischer P, Farcau O, Stefanescu H. Metabolomics: From liver chiromancy to personalized precision medicine in advanced chronic liver disease. World J Hepatol 2018; 10(3): 371-378
URL: https://www.wjgnet.com/1948-5182/full/v10/i3/371.htm
DOI: https://dx.doi.org/10.4254/wjh.v10.i3.371